The Rizatriptan Benzoate Tablets, cataloged under National Stock Number 6505-01-659-2917, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Teva Pharmaceuticals Usa, Inc.. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-659-2917 |
| Primary Part Number | NDC00093-7472-43 |
| Item Name | Rizatriptan Benzoate Tablets |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Teva Pharmaceuticals Usa, Inc. |
| Status | ACTIVE |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| NDC51407-0682-18 | Golden State Medical Supply, Inc. Dba Golden State Medical Supply Inc (USA) |
| NDC00093-7472-43 PRIMARY | Teva Pharmaceuticals Usa, Inc. (USA) |
| Reference | Meaning |
|---|---|
| 6505NCM163115 | 5/1 Secondary reference Defense Medical Standardization Board |
| MAXALT 10 MG TABLET 18S | 5/1 Secondary reference Merck Sharp & Dohme Llc |
| 1427364 | 5/1 Secondary reference U.S. Government activity |
NSN 6505-01-659-2917 is a Rizatriptan Benzoate Tablets, manufactured by Teva Pharmaceuticals Usa, Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-659-2917 has 2 manufacturer part numbers on file: NDC51407-0682-18 (Golden State Medical Supply, Inc. Dba Golden State Medical Supply Inc), NDC00093-7472-43 (Teva Pharmaceuticals Usa, Inc.).
Key specifications for NDC00093-7472-43: Special Features: RIZATRIPTAN BENZOATE 10MG TABLETS; INDICATED FOR THE ACUTE TREATMENT OF MIGRAINE WITH OR WITHOUT AURA IN ADULTS AND IN PEDIATRIC PATIENTS 6 TO 17 YEARS OLD; EACH TABLET CONTAINS 14.53 MG OF RIZATRIPTAN BENZOATE, EQUIVALENT TO 10 MG RIZATRIPTAN; SUPPLIED IN A BOX CONTAINING 18 UNIT-DOSE TABLETS; STRENGTH: 10 MG; STORE AT ROOM TEMPERATURE, 59-86 F (15-30 C).; Part Name Assigned by Controlling Agency: MAXALT (RIZATRIPTAN) TABLETS, 10 MG, 18S. 0 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.